Relationship Between Central Sensitization Symptoms and Cognitive Dysfunction in Fibromyalgia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

About this trial

The aim of the study is to investigate the relationship between central sensitization parameters and cognitive dysfunction in patients with fibromyalgia.The main questions it aims to answer are:

Do central sensitization symptoms affect cognitive dysfunction in patients with fibromyalgia? To what extent do central sensitization symptoms affect objective and subjective cognitive complaints in fibromyalgia patients? How do cognitive complaints relate to other clinical parameters, including disease severity, in these patients?

Eligibility criteria

Qualifiers

Being diagnosed with fibromyalgia according to American College of Rheumatology 2016 criteria

Being between 18-65 years old

Being literate

Accepting to participate in the study

Disqualifiers

Concomitant systemic inflammatory disease, central nervous system disease (cortical involvement), active infection and malignancy history

History of illness that may lead to cognitive impairment

Being <18 and >65 years old

Being illiterate

Trial design

Treatments tested in this trial

  • Central Sensitization Inventory
  • The Montreal Cognitive Assessment
  • Cognitive Symptom Severity Scale-Extended
  • Fibromyalgia Impact Questionnaire
  • Numeric rating scale
  • Hospital Anxiety and Depression Scale

Treatment groups

100 Participants
are divided into 1 treatment group